This research was performed to evaluate the potential of the CPPs with tumor-concentrating on Qualities to provide a cytotoxic payload to HCC cells. We explored using a CXCR4-targeting peptide, T22, fused with cytotoxic peptide PE24, to be a novel therapeutic strategy for CXCR4+ HCC cells. T22 was decided on as https://carole885tvv6.webdesign96.com/profile